FDA Halts Two Gene Therapy Trials After Child Develops Brain Tumor

(MedPage Today) — The FDA halted studies of two investigational gene therapies for rare pediatric diseases after a child treated in a clinical trial developed a brain tumor, RegenxBio said Wednesday.
The holds affect RGX-111 and RGX-121, therapies…